UnitedHealth Group's stock has plunged nearly 50% due to the CEO resignation, withdrawal of guidance, and ongoing legal issues, creating a potential buying opportunity. The stock is deeply oversold with an RSI of 15, trading below both the 200-day and 50-day moving averages, indicating capitulation.

U.S. equities were mixed at midday, with the Dow Jones Industrial Average and S&P 500 slightly higher and the Nasdaq marginally lower.

UnitedHealth Group announced that CEO Andrew Witty is stepping down due to 'personal reasons,' Stephen Hemsley will replace him.

UnitedHealth has been hammered in a number of ways: increased costs, political pressure over its size, and scrutiny by the Federal Trade Commission and Department of Justice. Cong

UNH shares plunge impacts 391 ETFs, shaking institutional & retail investors. Explore top ETFs most affected and what's behind the company's downturn.

UnitedHealth Group's stock has collapsed nearly 50% in 2025 after a leadership shake-up, surging medical costs, and a DOJ criminal probe into Medicare fraud.

UnitedHealth faces valuation reset amid CEO change, regulatory probes, and cost overruns. Click here for a full analysis of UNH stock.